{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:47:42Z","timestamp":1788317262602,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:00:00Z","timestamp":1760140800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["22120240325"],"award-info":[{"award-number":["22120240325"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172706"],"award-info":[{"award-number":["82172706"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373274"],"award-info":[{"award-number":["82373274"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.mtbio.2025.102409","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T14:53:00Z","timestamp":1760280780000},"page":"102409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Biomimetic nanovesicle vaccines derived from dendritic cells sensitized with whole tumor antigens for melanoma immunotherapy"],"prefix":"10.1016","volume":"35","author":[{"given":"Jiaye","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengze","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quangang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5603-745X","authenticated-orcid":false,"given":"Zongguang","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3789-7096","authenticated-orcid":false,"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.mtbio.2025.102409_bib1","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41392-021-00827-6","article-title":"Signal pathways of melanoma and targeted therapy","volume":"6","author":"Guo","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"10","key":"10.1016\/j.mtbio.2025.102409_bib2","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.mtbio.2025.102409_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"issue":"17","key":"10.1016\/j.mtbio.2025.102409_bib4","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1200\/JCO.22.02575","article-title":"Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now","volume":"41","author":"Long","year":"2023","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102409_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41392-020-00448-5","article-title":"Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer","volume":"6","author":"Ding","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102409_bib6","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s43018-022-00418-6","article-title":"Cancer vaccines: the next immunotherapy frontier","volume":"3","author":"Lin","year":"2022","journal-title":"Nat. Cancer"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102409_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41568-021-00346-0","article-title":"Therapeutic cancer vaccines","volume":"21","author":"Saxena","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102409_bib8","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1158\/1078-0432.CCR-20-0245","article-title":"The changing landscape of therapeutic cancer vaccines-novel platforms and neoantigen identification","volume":"27","author":"Jou","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.mtbio.2025.102409_bib9","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.mtbio.2025.102409_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2017.12.002","article-title":"Dendritic cells in the regulation of immunity and inflammation","volume":"35","author":"Qian","year":"2018","journal-title":"Semin Immunol"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102409_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102409_bib12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/1078-0432.CCR-14-1860","article-title":"Immune escape mechanisms as a guide for cancer immunotherapy","volume":"21","author":"Beatty","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.mtbio.2025.102409_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41577-019-0200-1","article-title":"Engineering universal cells that evade immune detection","volume":"19","author":"Lanza","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.mtbio.2025.102409_bib14","first-page":"1021","article-title":"A phase I trial of tumor lysate-pulsed dendritic cells in the treatment of advanced cancer","volume":"8","author":"Chang","year":"2002","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102409_bib15","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1464-410X.2004.04922.x","article-title":"Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I\/II study","volume":"94","author":"Pandha","year":"2004","journal-title":"BJU Int."},{"issue":"7780","key":"10.1016\/j.mtbio.2025.102409_bib16","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","article-title":"MHC-II neoantigens shape tumour immunity and response to immunotherapy","volume":"574","author":"Alspach","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102409_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41392-024-01735-1","article-title":"Extracellular vesicles as tools and targets in therapy for diseases","volume":"9","author":"Kumar","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.mtbio.2025.102409_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"issue":"7","key":"10.1016\/j.mtbio.2025.102409_bib19","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41565-021-00931-2","article-title":"Extracellular vesicles as a next-generation drug delivery platform","volume":"16","author":"Herrmann","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102409_bib20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12951-021-00986-2","article-title":"Artificial exosomes for translational nanomedicine","volume":"19","author":"Li","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2025.102409_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627932","article-title":"Cancer vaccines, adjuvants, and delivery systems","volume":"12","author":"Paston","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mtbio.2025.102409_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.940047","article-title":"Vaccine adjuvants to engage the cross-presentation pathway","volume":"13","author":"Lee","year":"2022","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.mtbio.2025.102409_bib23","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.3c11464","article-title":"Dual-responsive nanomedicine activates programmed antitumor immunity through targeting lymphatic system","volume":"18","author":"Xiao","year":"2024","journal-title":"ACS Nano"},{"issue":"7736","key":"10.1016\/j.mtbio.2025.102409_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.mtbio.2025.102409_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114020","article-title":"Delivery of STING agonists for adjuvanting subunit vaccines","volume":"179","author":"Van Herck","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"8","key":"10.1016\/j.mtbio.2025.102409_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081811","article-title":"The dynamics of the skin's immune system","volume":"20","author":"Nguyen","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2025.102409_bib27","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41565-024-01826-8","article-title":"Autophagosomes coated in situ with nanodots act as personalized cancer vaccines","volume":"20","author":"Huang","year":"2025","journal-title":"Nat. Nanotechnol."},{"issue":"19","key":"10.1016\/j.mtbio.2025.102409_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195912","article-title":"Advances of microneedles in biomedical applications","volume":"26","author":"Xu","year":"2021","journal-title":"Molecules"},{"issue":"30","key":"10.1016\/j.mtbio.2025.102409_bib29","doi-asserted-by":"crossref","first-page":"17543","DOI":"10.1073\/pnas.2005794117","article-title":"Tumor cell lysate-loaded immunostimulatory spherical nucleic acids as therapeutics for triple-negative breast cancer","volume":"117","author":"Callmann","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"22","key":"10.1016\/j.mtbio.2025.102409_bib30","doi-asserted-by":"crossref","first-page":"9410","DOI":"10.1021\/acs.nanolett.1c02582","article-title":"Equipping cancer cell membrane vesicles with functional DNA as a targeted vaccine for cancer immunotherapy","volume":"21","author":"Liu","year":"2021","journal-title":"Nano Lett."},{"issue":"20","key":"10.1016\/j.mtbio.2025.102409_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202006007","article-title":"Development of a cancer vaccine using in vivo click-chemistry-mediated active lymph node accumulation for improved immunotherapy","volume":"33","author":"Qin","year":"2021","journal-title":"Adv. Mater."},{"issue":"15","key":"10.1016\/j.mtbio.2025.102409_bib32","doi-asserted-by":"crossref","first-page":"18590","DOI":"10.1021\/acsami.2c20846","article-title":"Aptamer-functionalized nanovaccines: targeting in vivo DC subsets for enhanced antitumor immunity","volume":"15","author":"Zheng","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"issue":"6","key":"10.1016\/j.mtbio.2025.102409_bib33","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1084\/jem.20161674","article-title":"Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes","volume":"214","author":"Cerboni","year":"2017","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.mtbio.2025.102409_bib34","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4049\/jimmunol.1601999","article-title":"Cutting edge: activation of STING in T cells induces type I IFN responses and cell death","volume":"199","author":"Larkin","year":"2017","journal-title":"J. Immunol."},{"issue":"6284","key":"10.1016\/j.mtbio.2025.102409_bib35","doi-asserted-by":"crossref","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102409_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity - basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102409_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12951-023-01832-3","article-title":"A \u201ctrained immunity\u201d inducer-adjuvanted nanovaccine reverses the growth of established tumors in mice","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2025.102409_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.immuni.2023.12.005","article-title":"Multi-omics analysis of innate and adaptive responses to BCG vaccination reveals epigenetic cell states that predict trained immunity","volume":"57","author":"Moorlag","year":"2024","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.mtbio.2025.102409_bib39","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41565-023-01553-6","article-title":"Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity","volume":"19","author":"Liu","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.mtbio.2025.102409_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28093740","article-title":"Anticancer effect of STING agonist-encapsulated liposomes on breast cancer","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.mtbio.2025.102409_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004232","article-title":"ISA101 and nivolumab for HPV-16(+) cancer: updated clinical efficacy and immune correlates of response","volume":"10","author":"Sousa","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.mtbio.2025.102409_bib42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamaoncol.2022.5370","article-title":"Association of autologous tumor lysate-loaded dendritic cell vaccination with extension of survival among patients with newly diagnosed and recurrent glioblastoma: a phase 3 prospective externally controlled cohort trial","volume":"9","author":"Liau","year":"2023","journal-title":"JAMA Oncol."},{"issue":"26","key":"10.1016\/j.mtbio.2025.102409_bib43","article-title":"Fragment autoantigens stimulated T-Cell-Immunotherapy (FAST) as a fast autologous cancer vaccine","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.mtbio.2025.102409_bib44","article-title":"Dendritic cell vaccination in conjunction with a TLR agonist polarizes interferon immune responses in malignant glioma patients","author":"Everson","year":"2023","journal-title":"Res Sq"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425009809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006425009809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:53:36Z","timestamp":1766397216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006425009809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S2590006425009809"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102409","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomimetic nanovesicle vaccines derived from dendritic cells sensitized with whole tumor antigens for melanoma immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2025.102409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102409"}}